Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/08/2021 22 0
COV2-2050 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 2 0
COV2-2381 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 2 0
Cov2-16 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
CoV2-09 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
CoV2-14 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
CoV2-26 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
CoV2-06 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
COV2-2196 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/15/2020 1 0